News

Health officials have linked ground bison meat to a multistate outbreak of E coli O103 and E coli O121 infections.

Several states have or are considering laws that would circumvent consent from anti-vax parents.

The guidelines include a new section featuring recommendations for treating transgender people living with HIV.

RECARBRIO (imipenem, cilastatin, and relebactam) has been approved for the treatment of complicated urinary tract infections and complicated intra-abdominal bacterial infections where there are limited or no alternative treatments available.

Mosaico plans to register 3800 HIV-negative participants aged 18 to 60 years when enrollment opens later this year.

The Congolese city is home to more than 2 million people and rests against the border of Rwanda, a nation that is potentially vulnerable to the spread of Ebola.

The regulations require that hospitals in New York follow protocols for sepsis that include early detection and treatment, staff training, and reporting of adherence and clinical outcomes to the state.

Long-acting reservoir-style PrEP implants could help solve adherence issues.

PrEP awareness among these MSM rose from 60% to 90% from 2014 to 2017, and PrEP use increased from 6% to 35%.

Infections associated with injection drug misuse are on the rise—here's why we need to pay attention.

This In the Literature piece details a study evaluating MRSA nasal screening’s effect on antimicrobial stewardship.

Here is a look at infectious disease-related US Food and Drug Administration news from the week of July 7, 2019.

We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

Of the 216 infants studied, 31.5% had delayed neurodevelopment and/or eye abnormalities and/or hearing deficits when evaluated as late as 32 months of age.

A 2-dose course of the vaccine reduced the incidence of herpes zoster significantly over a median-follow up of 21 months when compared with placebo.

Videos of individuals licking ice cream and placing these cartons back on freezer store shelves have gone viral, and this practice can pose public health risks.

The program combines PrEP administration along with evidence-based behavioral intervention to reduce HIV risk behavior for HIV-negative, opioid-dependent people who use drugs and are receiving treatment.

A new study evaluates timelines for C diff treatment, diagnosis, and isolation.

Identifying patients in electronic health records databases who would benefit from taking PrEP is much easier with the advent of an automated algorithm.

Interest in on-demand HIV pre-exposure prophylaxis may be increasing, according to a survey in Australia.

The phase 3 study is assessing whether a switch to dolutegravir plus lamivudine from TAF-containing HIV treatment regimens can successfully maintain viral suppression.

Investigators sought to identify potentially intervenable factors that affect mortality among PLWH in the city of San Francisco.

Recent patient death calls into question viability of effective treatment for recurrent C diff.

The study found that two-thirds of patients receive excess antibiotic treatment and that every excess day increased a patient's risk of adverse events by 5%.

Following the elimination of personal belief exemptions, the statewide rate of kindergartners without up-to-date status for required vaccinations decreased from 9.84% in 2013 to 4.87% in 2017.

Getting PrEP into the hands of those who stand to gain the most from it, including women in sub-Saharan Africa remains a challenge.

Although PrEP drugs are key to preventing HIV infection, a new study by French investigators found a high prevalence of high-risk human papillomavirus infection among MSM taking PrEP.